These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18524797)

  • 41. Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly.
    Selvarajah D; Webster J; Ross R; Newell-Price J
    Eur J Endocrinol; 2005 Apr; 152(4):569-74. PubMed ID: 15817912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment outcomes and mortality of 94 patients with acromegaly.
    Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER
    Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
    Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acromegalic gigantism with low serum level of growth hormone and elevated serum insulin-like growth factor-I.
    Miyazaki R; Yoshida T; Sakane N; Yasuda T; Umekawa T; Kondo M; Shimatsu A; Hizuka N; Sano T
    Intern Med; 1995 Mar; 34(3):183-7. PubMed ID: 7787324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?
    Rosario PW; Calsolari MR
    Arch Endocrinol Metab; 2016; 60(6):510-514. PubMed ID: 27982199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.
    Barkan AL; Halasz I; Dornfeld KJ; Jaffe CA; Friberg RD; Chandler WF; Sandler HM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3187-91. PubMed ID: 9329336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels.
    Yoshida T; Shimatsu A; Sakane N; Hizuka N; Horikawa R; Tanaka T
    J Clin Endocrinol Metab; 1996 Jan; 81(1):310-3. PubMed ID: 8550769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term treatment outcome in acromegaly.
    Holdaway IM; Rajasoorya CR; Gamble GD; Stewart AW
    Growth Horm IGF Res; 2003 Aug; 13(4):185-92. PubMed ID: 12914751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of insulin-like growth factor-I in diagnosis and management of acromegaly.
    Clemmons DR
    Endocr Pract; 2004; 10(4):362-71. PubMed ID: 15760781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.
    Kanakis GA; Chrisoulidou A; Bargiota A; Efstathiadou ZA; Papanastasiou L; Theodoropoulou A; Tigas SK; Vassiliadi DA; Tsagarakis S; Alevizaki M
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):681-688. PubMed ID: 27292418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Submandibular salivary gland volume is increased in patients with acromegaly.
    Manetti L; Bogazzi F; Brogioni S; Grasso L; Lupi I; Genovesi M; Cecconi E; Gasperi M; Martino E
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):97-100. PubMed ID: 12100076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of insulin-like growth factor (somatomedin) levels in acromegaly.
    Rieu M
    Horm Res; 1986; 24(2-3):112-5. PubMed ID: 3530936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of morbidity and mortality in acromegaly: an Italian survey.
    Arosio M; Reimondo G; Malchiodi E; Berchialla P; Borraccino A; De Marinis L; Pivonello R; Grottoli S; Losa M; Cannavò S; Minuto F; Montini M; Bondanelli M; De Menis E; Martini C; Angeletti G; Velardo A; Peri A; Faustini-Fustini M; Tita P; Pigliaru F; Borretta G; Scaroni C; Bazzoni N; Bianchi A; Appetecchia M; Cavagnini F; Lombardi G; Ghigo E; Beck-Peccoz P; Colao A; Terzolo M;
    Eur J Endocrinol; 2012 Aug; 167(2):189-98. PubMed ID: 22596288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncological complications of excess GH in acromegaly.
    Webb SM; Casanueva F; Wass JA
    Pituitary; 2002 Jan; 5(1):21-5. PubMed ID: 12638722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly.
    Clemmons DR; Bidlingmaier M
    Front Endocrinol (Lausanne); 2023; 14():1266339. PubMed ID: 38027199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Raloxifene lowers IGF-I levels in acromegalic women.
    Attanasio R; Barausse M; Cozzi R
    Eur J Endocrinol; 2003 Apr; 148(4):443-8. PubMed ID: 12656665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased Serum Sclerostin Levels in Patients With Active Acromegaly.
    Pekkolay Z; Kılınç F; Gozel N; Önalan E; Tuzcu AK
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31821453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum IGF-I levels in the diagnosis and monitoring of acromegaly.
    Brooke AM; Drake WM
    Pituitary; 2007; 10(2):173-9. PubMed ID: 17431794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.